The following section deals with manufacturing technologies of Pharmaceuticals and up-to-date pharmaceutical equipment
Avalon GloboCare (USA), a leading global developer of cell-based technologies and therapeutics, formed a new wholly owned. subsidiary, Avactis Biosciences.
Swedish Orphan Biovitrum AB and Novimmune SA have entered into an licence agreement for the global rights to an orphan drug candidate for the treatment of primary Haemophagocytic lymphohistiocytosis (HLH).
Kite, a Gilead Company, and Gadeta B.V have entered into a strategic collaboration to develop novel gamma delta TCR therapies in various cancers.
Innovest Global launched its anticipated Biotechnology & Health Services Division with the acquisition of a twenty percent interest in StemVax Therapeutics.
Taconic Biosciences and Cyagen Biosciences, global leaders in the generation of custom genetically engineered rodent models and associated services, announced a strategic partnership.
Sinovant Sciences, a Shanghai-based biopharmaceutical company dedicated to bringing innovative medicines to China and advancing Chinese biopharmaceutical innovation abroad, unveiled its pipeline and leadership team.
Novartis announced that it has entered into an exclusive license agreement with biotech companies Galapagos NV, Mechelen (Belgium) and MorphoSys AG, Planegg/Munich (Germany) regarding their compound MOR106.
The Hong Kong Polytechnic University will join forces with Axis Therapeutics, a newly established joint venture by Athenex, Inc. and Xiangxue Pharmaceutical.